Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, Scheidel B, Jakob V, Rodamer M, Cascorbi I, Doroshyenko O, Sörgel F, Fuhr U.
Kinzig-Schippers M, et al. Among authors: scheidel b.
Antimicrob Agents Chemother. 2005 May;49(5):1733-8. doi: 10.1128/AAC.49.5.1733-1738.2005.
Antimicrob Agents Chemother. 2005.
PMID: 15855489
Free PMC article.
Clinical Trial.